142 related articles for article (PubMed ID: 20345477)
41. Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results.
Niwa M; Ishikura S; Tatekawa K; Takama N; Miyakawa A; Kubota T; Kato E; Shibamoto Y
Radiat Oncol; 2020 Jan; 15(1):25. PubMed ID: 32000814
[TBL] [Abstract][Full Text] [Related]
42. Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.
Dhakal B; Fenske TS; Ramalingam S; Shuff J; Epperla N; Hosking P; Rein L; Banerjee A; Hari P; D'Souza A; Shah N; Siker M; Griepentrog GJ; Harris GJ; Wells TS; Erickson BA; Hamadani M
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):305-311.e2. PubMed ID: 28284742
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
44.
Jangam D; Sridhar K; Butzmann A; Samghabadi P; Plowey ED; Ohgami RS
Curr Eye Res; 2020 Dec; 45(12):1583-1589. PubMed ID: 32339039
[TBL] [Abstract][Full Text] [Related]
45. Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment.
Sassone M; Ponzoni M; Ferreri AJ
Best Pract Res Clin Haematol; 2017; 30(1-2):118-130. PubMed ID: 28288706
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa.
Nam SW; Woo KI; Kim YD
Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410
[TBL] [Abstract][Full Text] [Related]
47. Immunoglobulin G4 (IgG4)-Positive Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma and Idiopathic Orbital Inflammation.
Sohn EJ; Ahn HB; Roh MS; Jung WJ; Ryu WY; Kwon YH
Ophthalmic Plast Reconstr Surg; 2018; 34(4):313-319. PubMed ID: 28749851
[TBL] [Abstract][Full Text] [Related]
48. Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Mino T; Mihara K; Yoshida T; Takihara Y; Ichinohe T
Blood Cancer J; 2014 Sep; 4(9):e245. PubMed ID: 25215661
[No Abstract] [Full Text] [Related]
49. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
50. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study.
Desai A; Joag MG; Lekakis L; Chapman JR; Vega F; Tibshirani R; Tse D; Markoe A; Lossos IS
Blood; 2017 Jan; 129(3):324-332. PubMed ID: 27789481
[TBL] [Abstract][Full Text] [Related]
51. Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review.
Chung HU; Son JH
J Yeungnam Med Sci; 2022 Jan; 39(1):3-11. PubMed ID: 34521183
[TBL] [Abstract][Full Text] [Related]
52. Spectral-domain optical coherence tomography of conjunctival mucosa-associated lymphoid tissue lymphoma with presumed choroidal involvement.
Williams BK; Tsui I; McCannel TA
Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1837-40. PubMed ID: 20532548
[TBL] [Abstract][Full Text] [Related]
53. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
54. [MALT Lymphoma of the Conjunctiva in a 13-year old Child--5-Year Relapse-free Follow-up Following Antibiotic Treatment].
Höh H; Armbrust S; Decker T; Holland U; Balschat S
Klin Monbl Augenheilkd; 2016 Jan; 233(1):79-84. PubMed ID: 26609671
[TBL] [Abstract][Full Text] [Related]
55. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.
Ferreri AJ; Ponzoni M; Martinelli G; Muti G; Guidoboni M; Dolcetti R; Doglioni C
Haematologica; 2005 Nov; 90(11):1578-9. PubMed ID: 16266908
[TBL] [Abstract][Full Text] [Related]
56. Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.
Annibali O; Chiodi F; Sarlo C; Cortes M; Quaranta-Leoni FM; Quattrocchi C; Bianchi A; Bonini S; Avvisati G
Biomed Res Int; 2015; 2015():895105. PubMed ID: 26425558
[TBL] [Abstract][Full Text] [Related]
57. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells.
Lee MJ; Kim N; Choe JY; Khwarg SI; Jeon YK; Choung HK; Kim JE
PLoS One; 2015; 10(6):e0131458. PubMed ID: 26111022
[TBL] [Abstract][Full Text] [Related]
59. A woman and her canary: a tale of chlamydiae and lymphomas.
Ferreri AJ; Dolcetti R; Magnino S; Doglioni C; Cangi MG; Pecciarini L; Ghia P; Dagklis A; Pasini E; Vicari N; Dognini GP; Resti AG; Ponzoni M
J Natl Cancer Inst; 2007 Sep; 99(18):1418-9. PubMed ID: 17848672
[No Abstract] [Full Text] [Related]
60. The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Fukutsu K; Kase S; Ishijima K; Kinoshita R; Ishida S
Radiat Oncol; 2018 May; 13(1):95. PubMed ID: 29769097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
